<?xml version="1.0" encoding="UTF-8"?>
<p>In conclusion, our results demonstrate the safety of placental‐expanded mesenchymal‐like cells for the treatment of iatrogenic muscle injury in patients and provide preliminary results on the efficacy of this treatment. Our biomarker studies suggest that immunomodulation has a significant impact on regeneration and mediates at least partly the mode of action.</p>
